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for critically ill adults and children: a cochrane
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Abstract
Introduction: Automated weaning systems may improve adaptation of mechanical support for a patient’s
ventilatory needs and facilitate systematic and early recognition of their ability to breathe spontaneously and the
potential for discontinuation of ventilation. Our objective was to compare mechanical ventilator weaning duration
for critically ill adults and children when managed with automated systems versus non-automated strategies.
Secondary objectives were to determine differences in duration of ventilation, intensive care unit (ICU) and hospital
length of stay (LOS), mortality, and adverse events.
Methods: Electronic databases were searched to 30 September 2013 without language restrictions. We also
searched conference proceedings; trial registration websites; and article reference lists. Two authors independently
extracted data and assessed risk of bias. We combined data using random-effects modelling.
Results: We identified 21 eligible trials totalling 1,676 participants. Pooled data from 16 trials indicated that
automated systems reduced the geometric mean weaning duration by 30% (95% confidence interval (CI) 13% to
45%), with substantial heterogeneity (I2 = 87%, P <0.00001). Reduced weaning duration was found with mixed or
medical ICU populations (42%, 95% CI 10% to 63%) and Smartcare/PS™ (28%, 95% CI 7% to 49%) but not with
surgical populations or using other systems. Automated systems reduced ventilation duration with no
heterogeneity (10%, 95% CI 3% to 16%) and ICU LOS (8%, 95% CI 0% to 15%). There was no strong evidence of
effect on mortality, hospital LOS, reintubation, self-extubation and non-invasive ventilation following extubation.
Automated systems reduced prolonged mechanical ventilation and tracheostomy. Overall quality of evidence was high.
Conclusions: Automated systems may reduce weaning and ventilation duration and ICU stay. Due to substantial trial
heterogeneity an adequately powered, high quality, multi-centre randomized controlled trial is needed.
Introduction
Serious physiological and psychological sequelae are
associated with protracted invasive mechanical ventilation,
necessitating efficient processes to safely reduce and re-
move ventilator support, termed weaning [1,2]. Tools such
as weaning protocols and automated systems may faci-
litate systematic and early recognition of spontaneous
breathing ability and the potential for ventilation discon-
tinuation. These tools may reduce practice variation and
improve efficiency by emphasizing timely and objective
decision making [3]. A 2010 Cochrane review evaluating
the effectiveness of protocolized versus non-protocolized
weaning [4] found evidence of reduced duration of mech-
anical ventilation, weaning and intensive care unit (ICU)
stay using standardized weaning protocols but also signifi-
cant heterogeneity among studies.
Weaning from mechanical ventilation traditionally
occurs via clinician-directed adjustments to the level
of assistance provided by the ventilator culminating in
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a spontaneous breathing trial. Through continuous moni-
toring and real-time interventions, automated systems
theoretically provide improved adaptation of ventilatory
support to patients’ needs when compared to clinician-
directed weaning [5]. Several such systems are now
commercially available and include Smartcare/PS™ (Dräger-
Medical, Lübeck, Germany), Adaptive Support Ventilation
(ASV) (HamiltonMedical, Bonaduz, Switzerland), Auto-
mode (Siemens, Solna, Sweden), Proportional Assist
Ventilation (PAV+ The University of Manitoba, Canada
used under license by Covidien, Minneapolis, US),
Mandatory Minute Ventilation (MMV) (Dräger Medical),
Proportional Pressure Support (PPS) (DrägerMedical),
Neurally Adjusted Ventilatory Assist (NAVA) (Maquet,
Solna, Sweden) and Intellivent-ASV®(Hamilton Medical,
Rhäzüns, Switzerland). (see Additional file 1). Automation
of weaning potentially reduces avoidable delays as it is less
reliant on clinician recognition of changes in the patient’s
weaning status which can be influenced by clinician avail-
ability, expertise and work load.
There is a pressing imperative to identify efficiencies
in weaning resulting in reduced ventilation duration to
prevent ventilator associated morbidity and mortality,
and also to offer solutions to existing constraints in crit-
ical care services. The number of patients receiving
mechanical ventilation continues to increase due to im-
proved patient survival and population aging [6]. Costs
of care provision to these patients are substantial [7].
This increased demand is occurring alongside a reduced
supply of healthcare professionals qualified and skilled
in mechanical ventilation management and its weaning
[8,9]. If efficacious in terms of clinical outcomes, auto-
mated weaning systems could enable safe and efficient
management of weaning despite predicted staffing short-
ages. Therefore, our primary objective was to compare the
total weaning duration, defined as study randomization
to successful extubation for critically ill ventilated adults
and children managed with an automated weaning system
versus non-automated strategies. Secondary objectives
were to determine differences in ventilation duration, ICU
and hospital lengths of stay (LOS), mortality and adverse
events related to early or delayed extubation. More details
regarding this review can be found in the Cochrane
Database of Systematic Reviews [10].
Methods
Trials were eligible if they were randomized, compared
automated systems designed to reduce ventilator support
based on continuous monitoring of patient tolerance
and interpretation of real-time physiological changes to
non-automated weaning strategies including standard or
usual care and protocolized weaning, and were conducted
in critically ill adults and children over four weeks of age.
We included adults and children as the same tenets of
weaning apply [11]. Research Ethics Board approval and
participant consent were not required as this is a systematic
review including published and non-published data from
existing trials.
Two authors independently searched MEDLINE,
EMBASE, Cochrane Central Register of Controlled Trials,
CINAHL, LILACS, Web of Science, the Database of Ab-
stracts of Reviews of Effects and the Health Technology
Assessment Database up to 30 September 2013. We com-
bined search terms for automated systems with the
Cochrane highly sensitive search strategy for randomized
controlled trials; language restrictions did not apply. We
searched conference proceedings, trial registration web-
sites, reference lists of retrieved studies and review papers
and contacted trial authors and content experts.
Data extraction
Using a standardized form, two authors independently
extracted: study design and setting, participant charac-
teristics, inclusion/exclusion criteria, weaning methods
(intervention and control arms), sedation strategies and
study outcomes. We recorded randomization methods,
allocation concealment, blinding, frequency and handling
of missing data, adherence to intention-to-treat analysis,
and selective outcome reporting. We contacted corre-
sponding authors to seek further clarification on issues of
reporting or to obtain additional outcome data. Data
extractors were not blinded to study citations.
Assessment of methodological quality
Two authors independently assessed methodological qual-
ity and risk of bias using the domain-based evaluation rec-
ommended by The Cochrane Collaboration [12]. Domains
judged as high, low or unclear risk of bias included:
random sequence generation, allocation concealment,
blinding, incomplete outcome data, selective reporting
and other biases. We used assessment of risk of bias
to perform sensitivity analyses based on methodological
quality.
Statistical analyses
We calculated the difference in means, 95% confidence
intervals (CIs) and the standard error of that difference
for continuous outcomes. For dichotomous data, we de-
scribed treatment effects using risk ratios (RR) and 95%
CIs. We used random-effects models to calculate pooled
estimates as heterogeneity was anticipated [13]. As we
detected considerable skew in continuous outcomes, we
log transformed data for the primary analysis. For six tri-
als [14-19], we log transformed raw data obtained from
corresponding authors. For nine trials [20-28], we used
the mean and standard deviation (SD) on the unlogged
scale to calculate a mean and SD on the log transformed
scale using methods described by Higgins [12]. For six
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trials [29-34], we used the median and interquartile
range (IQR) of the unlogged data to approximate the
mean if not available using methods described by Hozo
and colleagues [35] and calculated an approximate SD
on the log scale from the IQR on the log scale [12]. We
exponentiated the difference in the mean of a variable
on the log scale to provide the ratio of geometric means
on the unlogged scale and reported this as a percentage
change and 95% CIs (reduction or increase) in geometric
mean for ease of understanding [36]. All analyses were
performed in Review Manager 5.2 [37].
Subgroup and sensitivity analyses
Pre-specified subgroup analyses were performed based
on ICU population grouped as either ‘medical and
mixed’ or ‘surgical’; the automated system evaluated; and
the non-automated weaning strategy used (protocolized
versus non-protocolized weaning). Due to limited num-
bers of studies we collapsed studies of medical or mixed
ICU population into one group. We were unable to per-
form a priori planned subgroup analyses according to
weaning classification (simple, difficult, prolonged [2]) as
no trials used this taxonomy; adult versus pediatric pop-
ulations as only one trial recruited children; and sedation
strategy as this was inadequately reported in most trials.
We conducted sensitivity analyses on unlogged data for
all continuous outcomes and on logged data for the pri-
mary outcome excluding trials with high risk of bias.
Assessment of heterogeneity and reporting bias
We evaluated clinical heterogeneity by qualitative assess-
ment of study differences in terms of study population,
ICU type, clinician involvement in weaning decision
making, and implementation of weaning and extubation
processes. Statistical heterogeneity was informally evalu-
ated from forest plots, and more formally using the Chi
square test (P <0.05, significant heterogeneity) and I2
statistic (I2 > 50%, moderate to substantial heterogeneity)
[12]. We constructed a funnel plot of the treatment effect
for the primary outcome against trial precision (standard
error). We identified sufficient studies (≥10) to formally
test for asymmetry [38].
Results
Of the retrieved 1,249 citations, 21 trials of 1,676 par-
ticipants were included (Figure 1). Twelve trials re-
cruited mixed or medical ICU populations (n = 871, 52%)
[14-16,18,21,23,25,27-31] and nine surgical ICU patients
(n = 805, 48%) [17,19,20,22,24,26,32-34]. Eight trials
evaluated Smartcare/PS™ (DrägerMedical) (n = 803, 48%)
[14,16,17,23,27,30,31,33], seven trials Adaptive Support
Ventilation (ASV) (HamiltonMedical) (n = 424, 25%)
[15,19,20,29,32,34], three trials Automode (Siemens)
[22,24,28] (n = 78. 5%), one trial Mandatory Minute
Ventilation DrägerMedical) [21], one trial Mandatory
Rate Ventilation [26], one trial Proportional Assist
Ventilation (PAV+) [18], and one trial describing a
non-commercial automated system [25]. Sixteen trials
[15,17-24,26,28-32,34] used protocolized weaning as the
comparator; five [10,16,25,27,33] used usual care (Table 1).
Most studies were of high methodological quality (Figure 2)
although no studies blinded participants or clinical
personnel.
Weaning duration
Pooled data from 16 trials reporting weaning duration
indicated a reduction using automated systems (mean
log hours −0.36, 95% CI −0.59 to −0.14, P = 0.001), equiva-
lent to a 30% (95% CI 13% to 45%) reduction in the geo-
metric mean. Statistically significant (P <0.00001) and
substantial (I2 = 87%) heterogeneity was noted (Figure 3).
Subgroup analyses according to ICU population demon-
strated reduced weaning duration in trials of mixed/med-
ical ICU patients (mean log hours −0.55, −1.00 to −0.10,
P = 0.02; 42% (10% to 63%) reduction in geometric mean).
No evidence of effect was found in trials including only
surgical ICU patients. Smartcare/PS™ reduced weaning
duration (mean log hours −0.33, −0.58 to −0.09, P = 0.008;
28% (7% to 49%) reduction in geometric mean) whereas
ASV (mean log hours −0.03, −0.11 to 0.05, P = 0.50; 3%
(5% increase to 10% reduction) reduction in geometric
mean) and other systems (mean log hours −0.54, −1.17 to
0.08, P = 0.09; 42% (8% increase to 69% reduction) reduc-
tion in geometric mean) did not (Figure 4). There
was no subgroup difference according to the weaning
method used in the control arm with broadly overlap-
ping CIs.
Randomization to first extubation
Pooled data from eleven trials reporting duration of
study randomization to first extubation (as opposed to
successful extubation used for weaning duration) demon-
strated a reduction favouring automated systems (mean
log hours −0.20, −0.34 to −0.05, P = 0.007; 18% (5% to
29%) reduction in geometric mean), although statistically
significant (P = 0.0005) and substantial (I2 = 68%) hetero-
geneity was present.
Ventilation duration
Pooled data from 14 trials reporting total ventilation
duration indicated a reduction favouring automated sys-
tems (mean log hours −0.11, −0.18 to −0.03, P = 0.005;
10% (3% to 16%) reduction in geometric mean) with no
heterogeneity (I2 = 0%, P = 0.62) (Figure 5). There were
no subgroup differences according to ICU population,
automated system, or the weaning method used in the
control arm with broadly overlapping CIs for each sub-
group comparison.
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Mortality
Due to relatively wide CIs (RR 1.04, 0.83 to 1.31, P = 0.72),
pooled data from 12 trials did not provide strong evidence
that automated systems had an effect on mortality when
compared to non-automated weaning. Little heterogeneity
was noted (I2 = 3%) (Figure 6).
Duration of hospital and ICU stay
Pooled data from seven trials reporting hospital LOS
found no evidence of effect comparing automated systems
and non-automated weaning (mean log days −0.10, −0.21
to 0.02, P = 0.10; 6% (2% increase to 19% reduction) reduc-
tion in geometric mean) with no heterogeneity (I2 = 0%,
P = 0.52) (Figure 7). Pooled data from 13 trials reporting
ICU LOS demonstrated a reduction favouring automated
systems (mean log days −0.08, −0.16 to 0.00, P = 0.05; 8%
(0% to 15%) reduction in geometric mean) with moderate
heterogeneity (I2 = 49%, P = 0.02). Pooled data from stud-
ies conducted in mixed/medical ICU populations demon-
strated reduced ICU stay (mean log days −0.18, −0.32
to −0.04, P = 0.01; 15% (4% to 25%) reduction in geometric
mean) but trials in surgical ICU populations did not
(mean log days 0.02, − 0.02 to 0.06, P = 0.29; 2% (2%
reduction to 6% increase) increase in geometric mean)
(Figure 8). Pooled data from Smartcare/PS™ trials identified
reduced ICU stay (mean log days −0.26, −0.43 to −0.09,
P = 0.003; 23% (9% to 35%) reduction in geometric mean)
whereas ASV trials did not (mean log days 0.02, −0.02 to
0.06, P = 0.39; 2% (2% reduction to 6% increase) increase
in the geometric mean).
Adverse events
We did not find strong evidence that automated systems
had an effect on reintubation rates in the 13 trials
reporting this outcome (RR 0.80, 0.61 to 1.05, P = 0.1),
rates of self-extubation (RR 1.24, 0.58 to 2.67, P = 0.58; 9
trials), and non-invasive ventilation after extubation (RR
0.73, 0.53 to 1.02, P = 0.07; 12 trials). Prolonged mechan-
ical ventilation (RR 0.51, 0.27 to 0.95, P = 0.03; 7 trials)
(Figure 9), and tracheostomy (RR 0.67, 0.50 to 0.90,
P = 0.008, 9 trials) were reduced in favour of automated
systems (Figure 10).
1249 of records identified through 
database searching
(175 from the updated search 
[August 2012 to Sept 2013])
95 of additional records identified 
through other sources
1192 of records after duplicates 
removed
1192 of records screened, 
includes: 
1097 from electronic databases, 
91 studies from trial databases 
and abstract searching; 
2 full text articles from experts 
2 abstracts from experts
1137 of records excluded
1061/1097 from database 
search and expert referral
76/91 records from trial 
databases and abstract search
55 records for further review
40 records from electronic 
databases and expert referral 
(25 full-text articles and 15 
abstracts) (9 from new search)
15 records from trial databases 
and abstract search (8 from new 
search)
18 citations excluded
12/18 were abstracts reporting 
data later published as full-text
2/18 study design not RCT
2/18 not reporting on outcome 
of interest
1/18 not reporting on a closed 
loop system
1/18 did not apply closed loop 
system for duration of 
weaning
21 of studies included in 
qualitative and quantitative 
synthesis (meta-analysis)
6 abstracts awaiting 
classification
10 ongoing studies
Figure 1 Study flow diagram.
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Sensitivity analyses
We conducted sensitivity analyses to explore the effects
of automated systems prior to log-transforming data.
Overall, the pooled weaning duration demonstrated no
strong evidence of effect (mean hours −0.75, − 1.85
to 0.34, P = 0.18); however, substantial heterogeneity
was present (I2 = 72%, P <0.00001). Subanalyses ac-
cording to ICU population demonstrated reduced wean-
ing duration in mixed/medical ICU populations (mean
hours −18.75, −32.30 to −5.20, P = 0.007) but not surgical
ICU populations (mean hours −0.15, −0.70 to 0.39,
P = 0.58). Weaning duration was reduced in trials of
Smartcare/PS™ (mean hours - 38.46, −58.11 to −18.81,
P <0.001) but not ASV (mean hours −0.00, −0.07 to
0.06, P = 0.98) or other automated systems (mean
hours −3.89, −7.71 to 0.07, P = 0.05). Weaning dur-
ation was reduced in comparison to usual care (mean
hours −30.49, −60.63 to −0.35, P = 0.05, I2 = 52%) but
not when compared to a protocolized approach. There
was no evidence of effect in other measured continuous
outcomes. A sensitivity analysis exploring the effect of
studies with high risk of bias [27] continued to demon-
strate reduced weaning duration using automated systems
(mean log hours −0.37, −0.61 to −0.13, P = 0.003; 31%,
12% to 46% reduction in geometric mean).
Discussion
Based on pooled data from 16 eligible trials reporting
weaning duration, our study shows automated systems
reduced weaning duration by 30% in the geometric mean.
Table 1 Characteristics of included studies
Study Patients System Comparator Weaning success
Agarwal, 2013 [29] 48 adults ASV Protocolized: VCV to PSV Not defined
Aghadavoudi, 2012 [20] 81 adults ASV Protocolized: Not defined
SIMV (VC) + PS to CPAP
Burns, 2013 [30] 92 adults Smartcare/PS Protocolized: PSV Not defined although outcomes reported
for first and successful extubation
Davis, 1989 [21] 40 adults MMV Protocolized: IMV to CPAP Not defined
Dongelmans, 2009 [19] 128 adults ASV Protocolized: PCV to PSV Tracheal extubation
Hendrix, 2006 [22] 20 adults Automode Protocolized: PRVC to PSV Not defined
Jouvet, 2013 [14] 30 children Smartcare/PS Usual care: PSV No further need for ventilation for 48 hours
after extubation
Kirakli, 2011 [15] 97 adults ASV Protocolized: No further need for ventilation for 48 hours
after extubation or with a tracheostomy
cannula at day 28AC (VC) to PSV
Lellouche, 2006 [23] 147 adults Smartcare/PS Protocolized: PSV or T-piece Time from inclusion until successful extubation
(followed by 72 hours without ventilator support)
Liu, 2013 [31] 39 adults Smartcare/PS Protocolized: daily 30 min SBT
of CPAP or PSV
48 hours without reintubation after extubation
Petter, 2003 [32] 34 adults ASV Protocolized: SIMV to PSV Not defined
Ramet, 2002 [28] 18 children Automode Protocolized: PRVC to VS Not defined
Rose, 2008 [16] 102 adults Smartcare/PS Usual care: PSV No further need for ventilation for 48 hours
after extubation
Roth, 2001 [24] 40 adults Automode Protocolized: SIMV to PSV Not defined
Schädler, 2012 [17] 300 adults Smartcare/PS Protocolized: PSV Not defined though outcomes reported for
first and successful extubation
Stahl, 2009 [33] 60 adults Smartcare/PS Usual care: PSV Measured reintubation frequency within
48 hours of extubation
Strickland, 1993 [25] 17 adults Non-commercial system Usual care: SIMV to PSV/CPAP Not defined
Sulzer, 2001 [34] 36 adults ASV Protocolized: SIMV to PSV Not defined
Taniguchi, 2009 [26] 106 adults MRV Protocolized: PCV to PSV Not defined
Walkey [27] 33 adults Smartcare/PS Usual care: A/C to PSV No further need for ventilation for 48 hours
after extubation
Xirouchaki, 2008 [18] 208 adults PAV+ Protocolized: PSV Not defined
ASV, adaptive support ventilation; CPAP, continuous positive airway pressure; IMV, intermittent mandatory ventilation; MRV, minute respiratory volume; PAV+,
proportional assist ventilation; PRVC, pressure regulated volume control; PSV, pressure support ventilation; SBT, spontaneous breathing trial; SIMV, synchronized
intermittent mandatory ventilation; VS, volume support.
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Figure 2 Risk of bias summary.
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Figure 3 Duration of weaning by study population.
Figure 4 Duration of weaning by automated system.
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Figure 5 Duration of ventilation by automated system.
Figure 6 Mortality.
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Interpretation of the clinical relevance of a 30% reduction
in the geometric mean is challenging as the number of
hours reduced is dependent on the duration of weaning
for a given population. As illustration, if the mean
duration of weaning was 24 hours as reported in a
large international cohort of ventilated patients [39], a 30%
reduction equates to a 7.2 hour reduction in time spent
weaning. Subgroup analyses indicated weaning was reduced
in trials of mixed/medical ICU populations (42% geometric
mean) and Smartcare/PS™ (28% geometric mean) but not
in surgical ICU populations despite the inclusion of a 300
participant trial that excluded the typical postsurgical
‘easy-to-wean’ patient. We did not find evidence of effect
using automated systems other than Smartcare/PS™. The
method of weaning in the trial comparator arms (protocol
or non-protocolized usual care) did not influence the
effect of automated systems on the duration of weaning.
Due to substantial heterogeneity caution must be used
when interpreting these results. Automated systems also
reduced the time to first extubation, ventilation duration,
ICU LOS, tracheostomy and prolonged ventilation. There
was no strong evidence of an effect on mortality, reintuba-
tion, self-extubation, non-invasive ventilation (NIV) post-
extubation or hospital LOS.
When un-logged data were examined, no difference in
weaning duration was detected. However, a statistically
significant and clinically meaningful (>1 day) difference
in weaning duration was found in trials of mixed and
medical ICU populations and SmartCare/PS™. Disparate
findings in primary and sensitivity analyses are due to
trials of surgical patients being given more weight in the
unlogged analysis because of differences in relative sizes
Figure 7 Hospital length of stay.
Figure 8 ICU length of stay by study population.
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of the standard deviations meaning the overall conclu-
sion is much closer to zero. It is worth noting that
pooled estimates from logged and un-logged data in trials
of surgical patients are similar and are the same in mixed
and medical ICU populations.
Commercial availability of automated systems has led
to growing interest and enhanced feasibility in conducting
trials such that 13 of the 21 eligible trials were published
in the last five years. Most frequently evaluated systems
were Smartcare/PS™ and ASV. While SmartCare/PS™ has
an explicit algorithm for pressure support weaning, ASV
does not. Another notable difference in these systems is
that ASV automates switching from controlled to spon-
taneous ventilation if the patient’s spontaneous breathing
meets the minimum minute ventilation target whereas
Smartcare/PS™ requires clinician recognition of spon-
taneous breathing and activation of Smartcare/PS™. This
difference is important when considering the potential
impact on weaning and ventilation duration. Systems that
can switch automatically from controlled to spontaneous
breathing may have more influence on overall ventilation
duration than those that rely on clinician activation. These
systems may also reduce heterogeneity associated with
varying entry criteria for weaning commencement. How-
ever, we did not detect an effect on ventilation duration in
ASV trials due to inclusion of only surgical ICU patients
who generally do not experience protracted weaning and
ventilation.
We were unable to conduct subgroup analyses accord-
ing to the weaning classifications arising from the 2005
consensus conference [2] suggesting these are not yet
widely adopted as trial inclusion criteria or a priori sub-
group analyses. These classifications group patients in
terms of number or duration of weaning attempts and
may enable better identification of important subgroups
or guide patient selection criteria for future trials as
opposed to grouping patients according to admission
type. We found considerable variation in selection of
trial outcomes; indeed, only 71% reported weaning dur-
ation. This suggests the need for consensus on a mini-
mum core outcome set for such trials [40]. We identified
only two trials in a pediatric population, one in children
Figure 9 Prolonged mechanical ventilation.
Figure 10 Tracheostomy.
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older than two years due to the age and weight limits im-
posed by SmartCare/PS™. More than 50% of patients admit-
ted to paediatric ICUs are younger than two years old [41].
This lag in development of automated systems capable of
providing appropriate ventilation and weaning to all chil-
dren probably explains the lack of trials. Given the potential
for reduced weaning and ventilation durations, and the
small sample size of the two identified trials, there is a need
for commercial industry and researchers to further develop
and evaluate automated systems adapted to children.
Conclusions
In conclusion, automated systems may result in clinically
meaningful reduced durations of weaning, ventilation
and ICU stay. Overall, these systems appear to be safe
and can be considered a reasonable approach in the
management of ventilator weaning. These potential re-
ductions are more likely to occur in mixed/medical as
opposed to surgical ICU populations and with Smart-
care/PS™. Due to limited evidence on automated systems
other than Smartcare/PS™ and ASV no conclusions can
be drawn regarding their influence on outcomes. The
method of weaning to which automated systems was
compared (protocolized or non-protocolized usual care)
did not influence the effect on weaning duration. Due to
substantial heterogeneity in trials reporting weaning dur-
ation we believe there is a need for an adequately pow-
ered, high quality, multi-centre trial in an adult patient
population that excludes patients classified as ’simple to
wean’ with detailed description of ICU organizational
characteristics and weaning/sedation strategies in the
comparator arm as these may be contributing to clinical
heterogeneity. As little data exists on other automated sys-
tems and ASV in prolonged weaning, we are cautious to
recommend which should be selected for investigation.
Key messages
 Automated systems may reduce weaning and
ventilation duration particularly for mixed/medical
ICU populations.
 These systems may also reduce the need for
tracheostomy and prolonged mechanical ventilation.
 Thirteen of the 21 eligible trials were published in
the last five years indicating growing interest in
automated closed loop systems.
 There is a need for commercial industry
and researchers to further develop and
evaluate automated systems adapted to children.
Additional file
Additional file 1: Description of automated systems.
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